Adverse pregnancy outcomes in women at increased risk of preterm pre‐eclampsia on first‐trimester combined screening
BJOG: An International Journal of Obstetrics & Gynaecology · 2024
DOI: 10.1111/1471-0528.17560 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2024. Verfasst von Monica Minopoli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Pre-Eclampsia, Premature Birth. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Uteroplacental dysfunction may not only result in pre‐eclampsia (PE) but also in preterm birth (PTB), small‐for‐gestational‐age (SGA) birth and stillbirth. The aim of this study is to evaluate the positive predictive value (PPV) of first‐trimester combined PE screening for all of these placenta‐mediated adverse pregnancy outcomes.
Design
Retrospective cohort study.
Setting
Tertiary referral maternity unit. Sample A total of 13 211 singleton pregnancies.
Methods
First‐trimester combined screening for preterm PE using the Fetal Medicine Foundation (FMF) algorithm. Main outcomes measures Hypertensive disorders of pregnancy (HDP), PTB, SGA birth and stillbirth were combined to assess composite adverse and severe adverse pregnancy outcomes (CAPO and CAPO‐S). The PPVs for CAPO and CAPO‐S were calculated for women with a combined risk for preterm PE of ≥1 in 50 and ≥1 in 100.
Results
First‐trimester combined screening identified 2215 women (16.8%) with a risk of ≥1 in 100 for preterm PE. The PPVs for a risk of ≥1 in 100 for CAPO and CAPO‐S were 38.8% and 18.2%, respectively. The equivalent PPVs for a risk of ≥1 in 50 were 45.1% and 21.1%, respectively.
Conclusions
Women identified at high risk of preterm PE are also at increased risk of other placenta‐mediated adverse pregnancy outcomes, such as PTB, SGA birth and stillbirth. Women at high risk for preterm PE after first‐trimester screening may benefit from a higher surveillance care pathway, with interventions to mitigate all the adverse outcomes associated with placental dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.
- Department of Medicine and Surgery, Obstetrics and Gynaecology Unit, Università degli Study di Parma, Parma, Italy.
- Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
- Department of Medicine and Surgery, Obstetrics and Gynaecology Unit, Università degli Studi di Pavia, Pavia, Italy.
- Department of Medicine and Surgery, Obstetrics and Gynaecology Unit, Università degli Studi di Brescia, Brescia, Italy.
- Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
ORCID-Profile: Monica Minopoli, Anna Meroni
Zitieren
APA
Minopoli, M., Noël, L., Meroni, A., Mascherpa, M., Frick, A., & Thilaganathan, B. (2024). Adverse pregnancy outcomes in women at increased risk of preterm pre‐eclampsia on first‐trimester combined screening. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17560
Vancouver
Minopoli M, Noël L, Meroni A, Mascherpa M, Frick A, Thilaganathan B. Adverse pregnancy outcomes in women at increased risk of preterm pre‐eclampsia on first‐trimester combined screening. BJOG: An International Journal of Obstetrics & Gynaecology. 2024. doi:10.1111/1471-0528.17560
BibTeX
@article{Minopoli2024,
author = {Minopoli, Monica and Noël, Laure and Meroni, Anna and Mascherpa, Margaret and Frick, Alex and Thilaganathan, Basky},
title = {Adverse pregnancy outcomes in women at increased risk of preterm pre‐eclampsia on first‐trimester combined screening},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2024},
doi = {10.1111/1471-0528.17560}
}
EUVIMED